Research study Program year 2020 Source: CMS Open Payments

M16-045

ClinicalTrials.gov NCT03569293

Research payments

$6,962,255

1,245 payments

Through program year 2020, $6,962,255 in research payments was reported against M16-045, across 1,245 payments, paid by AbbVie, Inc..

Paid by: AbbVie, Inc.
ClinicalTrials.gov: NCT03569293

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$3,101,624	709
2019	Research	$3,860,631	536

Breakdown

Who paid Research payments · program years 2019–2020

AbbVie, Inc. $6,962,255 1,245 payments

Who received the money Research payments · program years 2019–2020

Mount Sinai School Of Medicine Organisation paid for research $671,240 20 payments
Probity Med Research Corporation Organisation paid for research $394,060 61 payments
Oregon Medical Research Center Organisation paid for research $334,224 45 payments
Uc Davis Medical Center Teaching hospital · CA $296,557 20 payments
Dermatology Clinical Trials Organisation paid for research $268,367 28 payments
Ricardo Antonio Tan MD INC Organisation paid for research $245,337 22 payments
Clinical Research Puerto Rico Organisation paid for research $223,537 33 payments
Alliance Dermatology & Mohs Center, Pc Organisation paid for research $215,861 14 payments
Menter Dermatology Research Institute Organisation paid for research $211,678 28 payments
Howland Allergy And Asthma Pllc Organisation paid for research $199,911 22 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.